|Articles|May 3, 2004
FDA approves new labeling claims for Tecnis IOL
Pfizer Inc. announces that the FDA has approved new labeling claims forits Tecnis IOL. The approval marks the first time a lens has received suchclaims for reduction of postoperative spherical abberations and improvednight-driving simulator performance, the company said in a prepared statement.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























